LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 271 of 520
Next
>>
>
6751 to 6775 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	KIN001-043	3.33	uM	LJP6	3	C08	72	hr	1334	3899	3921	0.9943	0.9927
BT-20	KIN001-043	10	uM	LJP6	1	C07	72	hr	1334	2821	3955	0.7131	0.6120
BT-20	KIN001-043	10	uM	LJP6	2	C07	72	hr	1334	2924	3899	0.7499	0.6604
BT-20	KIN001-043	10	uM	LJP6	3	C07	72	hr	1334	3258	3921	0.8308	0.7753
BT-20	Saracatinib	0.04	uM	LJP6	1	D12	72	hr	1334	3778	3955	0.9551	0.9422
BT-20	Saracatinib	0.04	uM	LJP6	2	D12	72	hr	1334	3734	3899	0.9577	0.9448
BT-20	Saracatinib	0.04	uM	LJP6	3	D12	72	hr	1334	4071	3921	1.0382	1.0488
BT-20	Saracatinib	0.12	uM	LJP6	1	D11	72	hr	1334	3681	3955	0.9305	0.9102
BT-20	Saracatinib	0.12	uM	LJP6	2	D11	72	hr	1334	3467	3899	0.8892	0.8537
BT-20	Saracatinib	0.12	uM	LJP6	3	D11	72	hr	1334	4066	3921	1.0369	1.0471
BT-20	Saracatinib	0.37	uM	LJP6	1	D10	72	hr	1334	3811	3955	0.9634	0.9530
BT-20	Saracatinib	0.37	uM	LJP6	2	D10	72	hr	1334	3360	3899	0.8617	0.8165
BT-20	Saracatinib	0.37	uM	LJP6	3	D10	72	hr	1334	3713	3921	0.9469	0.9310
BT-20	Saracatinib	1.11	uM	LJP6	1	D09	72	hr	1334	3346	3955	0.8459	0.7974
BT-20	Saracatinib	1.11	uM	LJP6	2	D09	72	hr	1334	3457	3899	0.8866	0.8503
BT-20	Saracatinib	1.11	uM	LJP6	3	D09	72	hr	1334	3654	3921	0.9318	0.9112
BT-20	Saracatinib	3.33	uM	LJP6	1	D08	72	hr	1334	3013	3955	0.7617	0.6811
BT-20	Saracatinib	3.33	uM	LJP6	2	D08	72	hr	1334	2972	3899	0.7622	0.6780
BT-20	Saracatinib	3.33	uM	LJP6	3	D08	72	hr	1334	3524	3921	0.8987	0.8672
BT-20	Saracatinib	10	uM	LJP6	1	D07	72	hr	1334	1936	3955	0.4894	0.2678
BT-20	Saracatinib	10	uM	LJP6	2	D07	72	hr	1334	1963	3899	0.5034	0.2833
BT-20	Saracatinib	10	uM	LJP6	3	D07	72	hr	1334	2290	3921	0.5840	0.4151
BT-20	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	1334	3267	3930	0.8311	0.7762
BT-20	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	1334	3559	4051	0.8785	0.8447
BT-20	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	1334	3708	4117	0.9005	0.8751

|<
<<
Previous
Page 271 of 520
Next
>>
>
6751 to 6775 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)